Company profile AMRX

Amneal Pharmaceuticals Inc
an american pharmaceutical company, amneal develops and produces affordable medicines. the company was built upon a family tradition of quality and integrity. everything amneal does, across the full spectrum of its business, is in service to these guiding principles. amneal is committed to constantly elevating and refining the value it delivers to its customers and patients a...round the globe. Show More
Quarter analysis & expected interestLast update: February 08 2024 14:45:02.

After 39 days of this quarter the interest is at 246.0. Based on that we can calculate that during remaining 52 days it will total up to 574.0.
That appears to be equal to previous quarter and same quarter last year.

YearQ1Q2Q3Q4
2019291
399
37.1% QoQ
487
22.1% QoQ
497
2.1% QoQ
2020 772
165.3% YoY 55.3% QoQ
691
73.2% YoY -10.5% QoQ
441
-9.4% YoY -36.2% QoQ
399
-19.7% YoY -9.5% QoQ
2021 507
-34.3% YoY 27.1% QoQ
448
-35.2% YoY -11.6% QoQ
485
10.0% YoY 8.3% QoQ
354
-11.3% YoY -27.0% QoQ
2022 438
-13.6% YoY 23.7% QoQ
393
-12.3% YoY -10.3% QoQ
397
-18.1% YoY 1.0% QoQ
312
-11.9% YoY -21.4% QoQ
2023 456
4.1% YoY 46.2% QoQ
416
5.9% YoY -8.8% QoQ
391
-1.5% YoY -6.0% QoQ
441
41.3% YoY 12.8% QoQ
2024 246
-46.1% YoY -44.2% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and Amneal Pharmaceuticals search interestLast update: February 08 2024 14:45:02.
Correlation coefficient between keyword and revenue is -0.25
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 08 2024 14:45:03.

The average 5 years interest of Amneal Pharmaceuticals was 35.48 per week.
The last year interest of Amneal Pharmaceuticals compared to the last 5 years has changed by -6.34%.
The interest for Amneal Pharmaceuticals is seasonal.
The last year interest is comparable to 5 years ago. It has changed only by -9.11%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Amneal Pharmaceuticals generics to provide analysis

Correlation between past revenue and Amneal Pharmaceuticals generics search interest

There is not enough data for Amneal Pharmaceuticals generics to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Amneal Pharmaceuticals generics to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Amneal Pharmaceuticals injectables to provide analysis

Correlation between past revenue and Amneal Pharmaceuticals injectables search interest

There is not enough data for Amneal Pharmaceuticals injectables to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Amneal Pharmaceuticals injectables to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Amneal Pharmaceuticals biosimilars to provide analysis

Correlation between past revenue and Amneal Pharmaceuticals biosimilars search interest

There is not enough data for Amneal Pharmaceuticals biosimilars to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Amneal Pharmaceuticals biosimilars to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Amneal Pharmaceuticals specialty branded pharmaceuticals to provide analysis

Correlation between past revenue and Amneal Pharmaceuticals specialty branded pharmaceuticals search interest

There is not enough data for Amneal Pharmaceuticals specialty branded pharmaceuticals to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Amneal Pharmaceuticals specialty branded pharmaceuticals to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Amneal Pharmaceuticals CNS disorders to provide analysis

Correlation between past revenue and Amneal Pharmaceuticals CNS disorders search interest

There is not enough data for Amneal Pharmaceuticals CNS disorders to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Amneal Pharmaceuticals CNS disorders to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Amneal Pharmaceuticals endocrine disorders to provide analysis

Correlation between past revenue and Amneal Pharmaceuticals endocrine disorders search interest

There is not enough data for Amneal Pharmaceuticals endocrine disorders to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Amneal Pharmaceuticals endocrine disorders to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: February 08 2024 14:45:08.

After 39 days of this quarter the interest is at 46.0. Based on that we can calculate that during remaining 52 days it will total up to 107.0.
Amneal Pharmaceuticals jobs expected interest is significantly lower compared to same quarter last year (-64.0%) but similar to previous quarter.

YearQ1Q2Q3Q4
2019190
139
-26.8% QoQ
205
47.5% QoQ
0
-100.0% QoQ
2020 97
-48.9% YoY inf% QoQ
118
-15.1% YoY 21.6% QoQ
120
-41.5% YoY 1.7% QoQ
133
inf% YoY 10.8% QoQ
2021 168
73.2% YoY 26.3% QoQ
94
-20.3% YoY -44.0% QoQ
216
80.0% YoY 129.8% QoQ
0
-100.0% YoY -100.0% QoQ
2022 272
61.9% YoY inf% QoQ
106
12.8% YoY -61.0% QoQ
187
-13.4% YoY 76.4% QoQ
182
inf% YoY -2.7% QoQ
2023 297
9.2% YoY 63.2% QoQ
165
55.7% YoY -44.4% QoQ
206
10.2% YoY 24.8% QoQ
110
-39.6% YoY -46.6% QoQ
2024 46
-84.5% YoY -58.2% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and Amneal Pharmaceuticals jobs search interestLast update: February 08 2024 14:45:08.
Correlation coefficient between keyword and revenue is 0.17
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 08 2024 14:45:10.

The average 5 years interest of Amneal Pharmaceuticals jobs was 11.69 per week.
The last year interest of Amneal Pharmaceuticals jobs compared to the last 5 years has changed by 4.45%.
This is something to be checked.
The last year interest is comparable to 5 years ago. It has changed only by 5.26%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Amneal Pharmaceuticals reviews to provide analysis

Correlation between past revenue and Amneal Pharmaceuticals reviews search interest

There is not enough data for Amneal Pharmaceuticals reviews to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Amneal Pharmaceuticals reviews to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Amneal Pharmaceuticals New Jersey to provide analysis

Correlation between past revenue and Amneal Pharmaceuticals New Jersey search interest

There is not enough data for Amneal Pharmaceuticals New Jersey to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Amneal Pharmaceuticals New Jersey to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Useful links and data for AMRX
Earnings date: 2024-03-01
Earnings date: 2024-03-01 After close
Company name: Amneal Pharmaceuticals Inc
Sector: Manufacturing
Company's website
Hypercharts
Yahoo Finance
MarketWatch
StockTwits
SEC Filings
SwaggyStocks
Latest articles

2026-05-12T05:00:00.000Z

US FDA
Approval of Pyridostigmine Bromide, Nda #217604 (Labeling)

2026-05-07T20:01:00Z

GlobeNewswire
Amneal Reports First Quarter 2026 Financial Results

2026-05-06T05:00:00.000Z

US FDA
Approval of Leuprolide Acetate, Anda #215336 (Labeling)

2026-04-27T05:00:00.000Z

US FDA
Approval of Lenalidomide, Anda #216213 (REMS)

2026-04-22T10:17:00Z

BusinessWire
Kashiv BioSciences Agrees to Be Acquired by Amneal Pharmaceuticals to Create a Fully Integrated Global Biosimilar Leader

2026-04-22T10:00:00Z

GlobeNewswire
Amneal Agrees to Acquire Kashiv BioSciences to Create Global Biosimilar Leader; Reports Strong Preliminary First Quarter 2026 Financial Results and Raises FY2026 Standalone Guidance

2026-04-20T12:00:00Z

GlobeNewswire
Amneal Announces Additional Positive Interim Phase 4 ELEVATE-PD Results with CREXONT® for Parkinson's Disease, Including Over 3 More Hours of Daily "Good On" Time When Switching from RYTARY®

2026-04-17T13:15:52Z

Analyst Upgrades
UBS Initiates Coverage On Amneal Pharmaceuticals with Buy Rating, Announces Price Target of $19

2026-04-14T12:00:00Z

GlobeNewswire
Amneal Launches First Two Respiratory Metered-Dose Inhalation Products in the U.S.

2026-04-09T12:00:00Z

GlobeNewswire
Amneal Launches Bimatoprost Ophthalmic Solution, 0.01%

2026-04-07T20:01:00Z

GlobeNewswire
Amneal to Report First Quarter 2026 Results on May 1, 2026

2026-04-07T12:00:00Z

GlobeNewswire
Amneal Announces $2 Million Donation to Support Patient Access to Essential Medicines During Parkinson's Awareness Month

2026-04-01T05:00:00.000Z

US FDA
Approval of Brexpiprazole, Anda #213562 (Labeling)

2026-03-06T05:00:00.000Z

US FDA
Approval of Nicardipine Hydrochloride, Anda #215406 (Labeling)

2026-03-05T21:05:00Z

GlobeNewswire
Amneal to Participate in Upcoming Investor Conference